why choose us

First received: May 09, 2024

Clinical Trial: Study of SPG601 in Adult Men With Fragile X Syndrome

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Fragile X Syndrome

Study Type: INTERVENTIONAL


Official Title: A Phase 2a, Randomized, Double-Blinded, Study Evaluating the Neurophysiologic vs Clinical Effects of Single-Dose SPG601 and Placebo in Adult Men With Fragile X Syndrome

Brief Summary: This Phase 2 study described herein will evaluate the safety, efficacy, tolerability, pharmacokinetics and pharmacodynamics of SPG601 in adult men with Fragile X syndrome.

Read more